We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,466
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MXCT icon
13226
CALL
MaxCyte
MXCT
$136M
$14.4K ﹤0.01%
2,900
-600
-17% -$2.96K
XTNT icon
13227
Xtant Medical Holdings
XTNT
$42.8M
$14.3K ﹤0.01%
22,503
-21,155
-48% -$15.4K
NVRI icon
13228
PUT
Enviri
NVRI
$579M
$14.3K ﹤0.01%
2,100
-2,200
-51% -$16.6K
SPRY icon
13229
PUT
ARS Pharmaceuticals
SPRY
$562M
$14.3K ﹤0.01%
+2,200
New +$16.9K
FBRT
13230
PUT
Franklin BSP Realty Trust
FBRT
$670M
$14.3K ﹤0.01%
1,200
-300
-20% -$4.02K
CNBS icon
13231
CALL
Amplify Seymour Cannabis ETF
CNBS
$76.5M
$14.3K ﹤0.01%
+283
New +$16.7K
AVAV icon
13232
AeroVironment
AVAV
$9.76B
$14.3K ﹤0.01%
156
-61,848
-100% -$5.48M
OMIC
13233
CALL
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$14.3K ﹤0.01%
393
+223
+131% +$13.7K
STOK icon
13234
PUT
Stoke Therapeutics
STOK
$2.02B
$14.2K ﹤0.01%
1,700
-2,700
-61% -$24.4K
CNNE icon
13235
PUT
Cannae Holdings
CNNE
$635M
$14.1K ﹤0.01%
700
+500
+250% +$11.1K
AMP icon
13236
Ameriprise Financial
AMP
$50.3B
$14.1K ﹤0.01%
46
-6,170
-99% -$2.02M
IHS icon
13237
PUT
IHS Holding
IHS
$2.82B
$14K ﹤0.01%
1,600
-400
-20% -$2.99K
VHC icon
13238
VirnetX Holding Corp
VHC
$62.8M
$14K ﹤0.01%
534
-3,291
-86% -$106K
BINI
13239
DELISTED
Bollinger Innovations
BINI
0
VERA icon
13240
PUT
Vera Therapeutics
VERA
$2.28B
$14K ﹤0.01%
+1,800
New +$13.9K
DPRO
13241
CALL
Draganfly
DPRO
$182M
$14K ﹤0.01%
436
-76
-15% -$3.13K
SPDN icon
13242
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$198M
$13.9K ﹤0.01%
+900
New +$14.3K
TTOO
13243
CALL
DELISTED
T2 Biosystems, Inc
TTOO
$13.9K ﹤0.01%
+303
New +$33.1K
WYY icon
13244
CALL
WidePoint Corp
WYY
$94.5M
$13.9K ﹤0.01%
7,700
+7,200
+1,440% +$14.5K
PROF
13245
PUT
Profound Medical
PROF
$241M
$13.9K ﹤0.01%
1,500
-5,600
-79% -$64.8K
ELDN icon
13246
CALL
Eledon Pharmaceuticals
ELDN
$288M
$13.9K ﹤0.01%
+5,900
New +$15.8K
SOFO
13247
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
$13.9K ﹤0.01%
15,926
-7,575
-32% -$6.8K
CURI icon
13248
PUT
CuriosityStream
CURI
$211M
$13.9K ﹤0.01%
10,300
-8,800
-46% -$14K
BF.A icon
13249
Brown-Forman Class A
BF.A
$13.3B
$13.9K ﹤0.01%
+213
New +$13.9K
G icon
13250
PUT
Genpact
G
$5.69B
$13.9K ﹤0.01%
+300
New +$14K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.